Studying gut bacteria in IBS and digestive issues
Part of Digestive system clinical trials.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have symptoms of IBS, small intestinal bacterial overgrowth (SIBO), or a functional GI disorder
- You are healthy enough for minor procedures (ASA class 1 or 2)
- You can read and understand English and agree to the study
- If you could become pregnant, you will use birth control and have a negative pregnancy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how your diet affects the bacteria in your gut. It is for healthy adults and people with irritable bowel syndrome (IBS) to see if certain foods change gut bacteria differently.
This study collects samples from your digestive tract during a routine upper endoscopy to learn about the tiny organisms (microbiome) in your small intestine. The goal is to better understand gut health and possibly improve future treatments.
This study looks at how gut bacteria may change in people who developed irritable bowel syndrome (IBS) after a stomach infection. Researchers hope to understand why some people recover completely while others develop ongoing digestive problems.
This study collects stool samples and health information to help develop a new test that may tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). If you have not been diagnosed with a chronic gut disorder, you may be able to join.
This study looks at how different ways of handling human samples affect the accuracy of gut bacteria analysis. It aims to improve testing methods, which could lead to better diagnosis and treatment for digestive conditions.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
Hear when a new Functional Gastrointestinal Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.